Private View: Discussing Women's Health

Dan Chichester
Dan Chichester

Hot flashes, weight gain, intimacy issues: these are old friends. Am I oversharing? The fact is that menopause and women's health was my entrée into healthcare. Helping evolve the Knowmenopause website also evolved my POV, as an ad professional—and as a human being. Learning medical details was “easy.” What confounded me was the tone-deaf surround-sound confronting too many women, from society… and even some health pros: “It's the same for everyone, honey, so deal!” Suddenly, I wasn't crafting clever promotions for B2B tech or 3-in-1 cable service. Now I had a responsibility to, and increasing respect for, individuals who were confronting this change—indeed, “The Change”—in their bodies and lives.

Even as I've engaged with other serious conditions, those first lessons stay with me. An opportunity to revisit the field, even through others' eyes, is a chance to reflect, anew, on what should drive all our contributions to an active health dialogue.

Here's to responsibility and respect…

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.